Telix Pharmaceuticals TLX
NASDAQ TLX
$9.26 +0.23 (+2.49%)
As of: Oct 28, 2026 · 3:40 PM EDT

Telix Pharmaceuticals (TLX) Accounts Payables (2023 - 2026)

Updated

Telix Pharmaceuticals' Accounts Payables was $168.97 million in the quarter ended Jun 30, 2026.

Analysis

Telix Pharmaceuticals (TLX) Accounts Payables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Accounts Payables at Telix Pharmaceuticals came in at $150.35 million, up 73.2% from the prior year.

  • In earlier years, Accounts Payables was $86.79 million in the year ended Dec 31, 2024 (+59.7%) and $54.33 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,155.96 Bn 1,124.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 654.45 Bn 574.31 Bn 17.30 Bn 9.32 Bn
3 AbbVie 507.05 Bn 480.16 Bn 12.70 Bn 33.30 Bn
4 Merck 347.92 Bn 302.30 Bn 12.21 Bn 3.83 Bn
5 Novartis Ag 302.89 Bn 276.13 Bn - -
6 Astrazeneca 263.00 Bn 236.69 Bn 12.86 Bn 22.89 Bn
7 Amgen 244.13 Bn 199.53 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 198.22 Bn 172.42 Bn 6.22 Bn 674.00 Mn
9 Pfizer 167.64 Bn 114.28 Bn 10.94 Bn 4.58 Bn
10 Telix Pharmaceuticals 3.13 Bn 2.08 Bn - 168.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168.97 Mn
Dec 31, 2025 150.35 Mn
Dec 31, 2024 87.03 Mn
Dec 31, 2023 55.77 Mn
API Access

Telix Pharmaceuticals Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=TLX&period=max&api_key=YOUR_API_KEY